Qualitative and quantitative measures of various compounded formulations of 17-hydroxyprogesterone caproate

OBJECTIVES: 17-hydroxyprogesterone caproate (17-OHPC) is available both as an FDA – approved medication and as a product prepared for individual patients by compounding pharmacies. Compounding pharmacies may omit the preservative used in the FDA approved formulation or use an alternate preservative...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: CARITIS, Steve N., ZHAO, Yang, BETTINGER, Joseph, VENKATARAMANAN, Raman
Médium: Artigo
Jazyk:Inglês
Vydáno: 2013
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3672260/
https://ncbi.nlm.nih.gov/pubmed/23453884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajog.2013.02.028
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky